Patents by Inventor James W. Crow

James W. Crow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease
    Patent number: 6054486
    Abstract: An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene) -13,14-dihydro-prostaglandin F.sub.1.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: April 25, 2000
    Assignee: United Technology Corporation
    Inventors: James W. Crow, Shelmer D. Blackburn, Jr., Robert Roscigno, Michael Wade, Gilles Cloutier, Martine Rothblatt
  • Treatment of congestive heart failure
    Patent number: 5234953
    Abstract: The present invention is concerned with the use of a compound of formula (I) ##STR1## wherein --W-- is ##STR2## wherein Z is --V(CH.sub.2).sub.b CO.sub.2 H where b is 1 or 2 and V is oxygen when b is 1 or methylene when b is 2;X is hydrogen, cyano, or --C.tbd.CH; andthe dotted line represents an optional double bond;and physiologically functional derivatives thereof,in the treatment of congestive heart failure.
    Type: Grant
    Filed: May 23, 1991
    Date of Patent: August 10, 1993
    Assignee: Burroughs Wellcome Co.
    Inventors: James W. Crow, Walker A. Long
  • Method of treating pulmonary hypertension with benzidine prostaglandins
    Patent number: 5153222
    Abstract: The present invention is concerned with methods for the prophylaxis, treatment and diagnosis of pulmonary hypertension which comprise the administrative of an effective amount of a compound of formula (I) ##STR1## wherein a is an integer of from 1 to 3; X and Y, which may be the same or different, are selected from --O-- and --CH.sub.2 --;R is --(CH.sub.2).sub.5 R.sup.1 wherein R.sup.1 is hydrogen or methyl, or R is cyclohexyl, orR is --CH(CH.sub.3)CH.sub.2 C.tbd.CCH.sub.3 ; andthe dotted line represents an optional double bond;or of a physiologically acceptable salt or acid derivative thereof.Medicaments and diagnostic aids for use in the methods of the invention are also within the scope of the invention.
    Type: Grant
    Filed: June 14, 1991
    Date of Patent: October 6, 1992
    Assignee: Burroughs Wellcome Co.
    Inventors: Anjaneyulu S. Tadepalli, Walker A. Long, James W. Crow, Kenneth B. Klein